HP1330 Contributes to Streptococcus suis Virulence by Inducing Toll-Like Receptor 2- and ERK1/2-Dependent Pro-inflammatory Responses and Influencing In Vivo S. suis Loads

2 (SS2) has evolved into a highly invasive pathogen responsible for two large-scale outbreaks of streptococcal toxic shock-like syndrome (STSLS) in China. Excessive inflammation stimulated by SS2 is considered a hallmark of STSLS, even it also plays important roles in other clinical symptoms of SS2-...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 8; p. 869
Main Authors Zhang, Qiang, Huang, Jingjing, Yu, Junping, Xu, Zhongmin, Liu, Liang, Song, Yajing, Sun, Xiaomei, Zhang, Anding, Jin, Meilin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 31.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:2 (SS2) has evolved into a highly invasive pathogen responsible for two large-scale outbreaks of streptococcal toxic shock-like syndrome (STSLS) in China. Excessive inflammation stimulated by SS2 is considered a hallmark of STSLS, even it also plays important roles in other clinical symptoms of SS2-related disease, including meningitis, septicemia, and sudden death. However, the mechanism of SS2-caused excessive inflammation remains poorly understood. Here, a novel pro-inflammatory protein was identified (HP1330), which could induce robust expression of pro-inflammatory cytokines (TNF-α, MCP-1, and IL-1β) in RAW264.7 macrophages. To evaluate the role of HP1330 in SS2 virulence, an deletion mutant ( ) was constructed. disruption led to a decreased pro-inflammatory ability of SS2 in RAW 264.7 macrophages. showed reduced lethality, pro-inflammatory activity, and bacterial loads in mice. To further elucidate the mechanism of HP1330-induced pro-inflammatory cytokine production, antibody blocking and gene-deletion experiments with macrophages were performed. The results revealed that the pro-inflammatory activity of HP1330 depended on the recognition of toll-like receptor 2 (TLR2). Furthermore, a specific inhibitor of the extracellular signal-regulated kinase 1/2 (ERK1/2) pathways could significantly decrease HP1330-induced pro-inflammatory cytokine production, and western blot analysis showed that HP1330 could induce activation of the ERK1/2 pathway. Taken together, our findings demonstrate that HP1330 contributes to SS2 virulence by inducing TLR2- and ERK1/2-dependent pro-inflammatory cytokine production and influencing bacterial loads, implying that HP1330 may be associated with STSLS caused by SS2.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Zsuzsa Szondy, University of Debrecen, Hungary; Takato Takenouchi, National Agriculture and Food Research Organization, Japan
Edited by: Tobias Schuerholz, Universitätsmedizin Rostock, Germany
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
These authors have contributed equally to this work.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.00869